CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-21 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +15,000 | $0.85 | $13K | 15,000 |
| 2017-08-21 | Yoo Stephen Chief Medical Officer | Sale | −15,000 | $20.03 | $300K | 0 |
| 2017-08-21 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 202,900 | ||
| 2017-08-21 | Mills Kenneth T. President and CEO | Sale | −6,500 | $20.05 | $130K | 105,500 |
| 2017-08-15 | Vasista Vittal Chief Financial Officer | Sale | −2,205 | $20.96 | $46K | 103,118 |
| 2017-08-15 | Vasista Vittal Chief Financial Officer | Sale | −835 | $21.43 | $18K | 102,283 |
| 2017-07-20 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +15,000 | $0.85 | $13K | 15,000 |
| 2017-07-20 | Yoo Stephen Chief Medical Officer | Sale | −15,000 | $18.66 | $280K | 0 |
| 2017-07-20 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 217,900 | ||
| 2017-07-20 | Mills Kenneth T. President and CEO | Sale | −6,500 | $18.66 | $121K | 112,000 |
| 2017-07-17 | Vasista Vittal Chief Financial Officer | Sale | −3,100 | $19.81 | $61K | 105,323 |
| 2017-06-30 | Christmas Patrick J. SVP, General Counsel | Grant or award | +655 | $15.73 | $10K | 655 |
| 2017-06-30 | Vasista Vittal Chief Financial Officer | Grant or award | +911 | $15.73 | $14K | 108,423 |
| 2017-06-20 | Yoo Stephen Chief Medical Officer | Exercise or conversion | +15,000 | $0.85 | $13K | 15,000 |
| 2017-06-20 | Yoo Stephen Chief Medical Officer | Sale | −13,100 | $19.61 | $257K | 1,900 |
| 2017-06-20 | Yoo Stephen Chief Medical Officer | Sale | −1,900 | $20.14 | $38K | 0 |
| 2017-06-20 | Yoo Stephen Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 232,900 | ||
| 2017-06-20 | Mills Kenneth T. President and CEO | Sale | −5,604 | $19.60 | $110K | 119,396 |
| 2017-06-20 | Mills Kenneth T. President and CEO | Sale | −896 | $20.16 | $18K | 118,500 |
| 2017-06-15 | Vasista Vittal Chief Financial Officer | Sale | −3,100 | $18.75 | $58K | 107,512 |
Page 47 of 56 · 1,104 trades